» Articles » PMID: 24060567

Vaccines Against Diseases Transmitted from Animals to Humans: a One Health Paradigm

Overview
Journal Vaccine
Date 2013 Sep 25
PMID 24060567
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

This review focuses on the immunization of animals as a means of preventing human diseases (zoonoses). Three frameworks for the use of vaccines in this context are described, and examples are provided of successes and failures. Framework I vaccines are used for protection of humans and economically valuable animals, where neither plays a role in the transmission cycle. The benefit of collaborations between animal health and human health industries and regulators in developing such products is discussed, and one example (West Nile vaccine) of a single product developed for use in animals and humans is described. Framework II vaccines are indicated for domesticated animals as a means of preventing disease in both animals and humans. The agents of concern are transmitted directly or indirectly (e.g. via arthropod vectors) from animals to humans. A number of examples of the use of Framework II vaccines are provided, e.g. against brucellosis, Escherichia coli O157, rabies, Rift Valley fever, Venezuelan equine encephalitis, and Hendra virus. Framework III vaccines are used to immunize wild animals as a means of preventing transmission of disease agents to humans and domesticated animals. Examples are reservoir-targeted, oral bait rabies, Mycobacterium bovis and Lyme disease vaccines. Given the speed and lost cost of veterinary vaccine development, some interventions based on the immunization of animals could lead to rapid and relatively inexpensive advances in public health. Opportunities for vaccine-based approaches to preventing zoonotic and emerging diseases that integrate veterinary and human medicine (the One Health paradigm) are emphasized.

Citing Articles

Climate change and contagion: the emerging threat of zoonotic diseases in Africa.

Edward M, Heniedy A, Saminu A, Mary J, Ahmed D, Engmann S Infect Ecol Epidemiol. 2024; 15(1):2441534.

PMID: 39703746 PMC: 11654033. DOI: 10.1080/20008686.2024.2441534.


Are we cultivating the perfect storm for a human avian influenza pandemic?.

Perez-Acle T, Ravello C, Rosemblatt M Biol Res. 2024; 57(1):96.

PMID: 39695812 PMC: 11658083. DOI: 10.1186/s40659-024-00570-6.


Integrating animal welfare into the WHO pandemic treaty: a thematic analysis of civil society perspectives and comparison with treaty drafting.

Huang Y, Jiang S, Daminova N, Kumah E Front Vet Sci. 2024; 11:1421158.

PMID: 39606645 PMC: 11599984. DOI: 10.3389/fvets.2024.1421158.


Anthrax: A narrative review.

Ashique S, Biswas A, Mohanto S, Srivastava S, Hussain M, Ahmed M New Microbes New Infect. 2024; 62:101501.

PMID: 39497912 PMC: 11532300. DOI: 10.1016/j.nmni.2024.101501.


Current Challenges of Vaccination in Fish Health Management.

Kumar A, Middha S, Menon S, Paital B, Gokarn S, Nelli M Animals (Basel). 2024; 14(18).

PMID: 39335281 PMC: 11429256. DOI: 10.3390/ani14182692.


References
1.
Cross M, Henderson R, Lambeth M, Buddle B, Aldwell F . Lipid-formulated bcg as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy, and palatability to brushtail possums (Trichosurus vulpecula) in New Zealand. J Wildl Dis. 2009; 45(3):754-65. DOI: 10.7589/0090-3558-45.3.754. View

2.
Anishchenko M, Bowen R, Paessler S, Austgen L, Greene I, Weaver S . Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation. Proc Natl Acad Sci U S A. 2006; 103(13):4994-9. PMC: 1458783. DOI: 10.1073/pnas.0509961103. View

3.
Gray G, Baker W . The importance of including swine and poultry workers in influenza vaccination programs. Clin Pharmacol Ther. 2007; 82(6):638-41. PMC: 2083258. DOI: 10.1038/sj.clpt.6100391. View

4.
Artois M, Masson E, Barrat J, Aubert M . Efficacy of three oral rabies vaccine-baits in the red fox: a comparison. Vet Microbiol. 1993; 38(1-2):167-72. DOI: 10.1016/0378-1135(93)90083-j. View

5.
Yeh J, Chung K, Song J . Differentiation of West Nile virus-infected animals from vaccinated animals by competitive ELISA using monoclonal antibodies against non-structural protein 1. Vector Borne Zoonotic Dis. 2012; 12(5):380-7. PMC: 3353758. DOI: 10.1089/vbz.2011.0796. View